Molecular characterization and in vitro differentiation of feline progenitor-like amniotic epithelial cells by L. Rutigliano et al.
Rutigliano et al. Stem Cell Research & Therapy 2013, 4:133
http://stemcellres.com/content/4/5/133RESEARCH Open AccessMolecular characterization and in vitro
differentiation of feline progenitor-like amniotic
epithelial cells
Lucia Rutigliano1†, Bruna Corradetti2†, Luisa Valentini1, Davide Bizzaro2, Aurora Meucci3, Fausto Cremonesi3,4*
and Anna Lange-Consiglio3Abstract
Introduction: While amniotic mesenchymal cells have been isolated and characterized in different species,
amniotic epithelial cells (AECs) have been found only in humans and horses and are recently considered valid
candidates in regenerative medicine. The aim of this work is to obtain and characterize, for the first time in
the feline species, presumptive stem cells from the epithelial portion of the amnion (AECs) to be used for
clinical applications.
Methods: In our study, we molecularly characterized and induced in vitro differentiation of feline AECs, obtained
after enzymatic digestion of amnion.
Results: AECs displayed a polygonal morphology and the mean doubling time value was 1.94 ± 0.04 days
demonstrating the high proliferating capacity of these cells. By RT-PCR, AECs expressed pluripotent (Oct4, Nanog)
and some mesenchymal markers (CD166, CD44) suggesting that an epithelial-mesenchymal transition may occur in
these cells that lack the hematopoietic marker CD34. Cells also showed the expression of embryonic marker SSEA-4,
but not SSEA-3, as demonstrated by immunocytochemistry and flow cytometry. Moreover, the possibility to use
feline AECs in cell therapies resides in their low immunogenicity, due to the absence of MHC-II antigen expression.
After induction, AECs differentiated into the mesodermic and ectodermic lineages, demonstrating high plasticity.
Conclusions: In conclusion, feline AECs appear to be a readily obtainable, highly proliferative, multipotent and
non-immunogenic cell line from a source that may represent a good model system for stem cell biology and be
useful in allogenic cell-based therapies in order to treat tissue lesions, especially with loss of substance.Introduction
The main applications of mesenchymal stem cells (MSCs)
in human medicine are in the therapy of hematological
disorders, cardiovascular degenerative diseases, genetic
and neurological disorders, and in tissue engineering [1],
but to date there are few clinical advances in other path-
ologies. Two essential factors are necessary to promote
the study in regenerative medicine: a good animal model
and an efficient source of stem cells.* Correspondence: fausto.cremonesi@unimi.it
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reproduction in any medium, provided the orSince many pathologies are very difficult to study in hu-
man medicine, the domestic cat could offer an attractive
animal model in order to explore different diseases with
similarities to the human ones, as well as hereditary condi-
tions (for example, autosomal dominant polycystic kidney
disease) [2], hereditary retinal blindness [3], inherited
muscular dystrophy [4], Niemann-Pick disease type C [5],
diabetic neuropathy [6], immunodeficiency or viral dis-
eases [7,8]. Moreover, since the cat genome project is
nearly complete, the establishment of pluri/multipotent fe-
line stem cells would facilitate targeting specific genetic
loci, and generating additional useful disease models in
the cat itself [9].
Regarding the stem cell reservoirs, the most character-
ized sources of MSCs are bone marrow (BM) [10-17]
and the adipose tissue [12,17]. Also, in 2002, MSCs fromral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cells appeared to be very similar to those obtained from
rodent and human sources [18], but the procedures
employed to isolate these tissues are invasive and cells
are usually obtained with low efficiency [18-20].
Extra-fetal tissues could offer the possibility of getting
over the limitations of adult stem cell sources [1,21-23].
Indeed, umbilical cord blood, umbilical cord matrix, am-
nion and amniotic fluid could provide a large amount of
cells without risks for the donor and in an inexpensive
and non-invasive way, since they are discarded at deliv-
ery, or can also be collected after cesarean section or in
case of ovario-hysterectomy of pregnant uteri. This is a
great concern for regenerative medicine, especially if
there is the chance to cryogenically bank them [24,25].
Among extra-fetal tissues, recently, amniotic membrane
appeared an important stem cell source in different spe-
cies, including human [26], horse [23,27], sheep [28], dog
[29] and cat [30]. The amniotic epithelium layer, while ori-
ginating from the trophectoderm as other parts of fetal
membranes, has the peculiarity of being continuous with
the epiblast [31]. For this reason it may probably preserve
some of the characteristics of the epiblast, like pluripo-
tency [32], as confirmed by the expression of different
pluripotent stem cell-specific transcription factors, such as
Sox2, Nanog, Oct4 and Rex1 [27,32-36]. Amniotic epithe-
lial cells (AECs) have been isolated and characterized in
different species, such as in the human [36], horse [27]
and sheep [37] and their pluripotency and plasticity are
demonstrated by in vitro differentiation into the cell lines
of the three germ layers [21,26,27,32,33,38-40]. The poten-
tial application of AECs in cell-based therapies relies not
only on their pluripotent features, but also on their im-
munogenic characteristics. In fact, they do not express
Major Histocompatibility Complex (MHC) Class II anti-
gens [21,27,41,42]. In addition, AECs actively secrete a
number of immunosuppressive factors with a consequent
failure of allogeneic lymphocyte responsiveness, which
may support survival following transplantation and en-
graftment [21,39,41-44].
The chance to characterize feline stem cells could be
helpful in cell-based therapies in human medicine for
the pathologies described above, but also in feline spe-
cies to treat tissue lesions especially characterized by loss
of substances. Moreover, these cells could also improve
the efficiency of interspecies somatic cell nuclear trans-
fer for preserving endangered felids [45] and could be
used in drug testing in therapeutic intervention, and
auto/allo/xenogenic transplantation.
Considering the reported context, in this study we iso-
lated and characterized, for the first time, in terms of
morphology, specific stemness and pluripotent markers,
proliferative and differentiative potential, the AECs from
the domestic cat.Materials and methods
Amnion collection
Uteri were recovered from three pregnant queens at 40
to 45 days of gestational age, brought to the veterinary
hospital by their owners to be spayed. In this study, after
approval by the Ethical Committee of the University of
Milan and the owner’s written consent, all procedures
were conducted following standard veterinary practice
and in accordance with 2010/63 EU directive on animal
protection and Italian Law (D.L. No. 116/1992). Accord-
ing to the ethical guidelines, during ovariohysterectomy,
care was given to maintain fetuses in the depressed state
from maternal anesthesia until vital signs (heart beats)
disappeared, as assessed by intra-surgical ultrasonog-
raphy, before removal of the gravid uterus.
Samples of allanto-amnion were kept in a 4°C in
phosphate-buffered saline (PBS) for not more than 24 h.
The amniotic membrane of each sample was mechanically
separated from the allantois and was cut into small pieces
before enzymatic digestion to isolate presumptive AECs.
Isolation of amniotic epithelial cells and cell culture
Amnion fragments were washed twice in Hank’s Balanced
Salt Solution (Euroclone, Milano, Italy. ECB-4007 L) sup-
plemented with penicillin 100 UI/ml/streptomycin 100 μg/
ml (Sigma, Aldrich, Milano, Italy. P-0781), and then incu-
bated for nine minutes at 37°C in a pre-warmed solution
of PBS containing 2.4 U/ml dispase (Becton Dickinson
and Company, Milano, Italy. 354235). After that, the frag-
ments were digested with 0.05% trypsin/0.02% EDTA
(Euroclone, ECB3052D) for 40 minutes at 37°C, in order
to obtain AECs. The suspension was filtered using 80 μm
filters (Millipore, Milan, Italy), and trypsin-undigested
amnion fragments were digested again with pre-warmed
0.25% trypsin (Sigma, T-4049), strongly shaking for one to
two minutes. After filtering again, trypsin in the suspen-
sion was neutralized with high glucose-Dulbecco’s modi-
fied Eagle’s medium (HG-DMEM; Euroclone, ECB7501L),
supplemented with 10% heat-inactivated fetal bovine
serum (FBS; Sigma Aldrich, F-7678) and AECs were
collected by centrifugation at 200 x g for 10 minutes.
Cells were cultured in HG-DMEM supplemented with
10% FBS, 10 ng/ml epidermal growth factor (Sigma,
E-9644), penicillin 100 UI/ml/streptomycin 100 μg/ml
(Sigma, P-0781), 0.25 μg/ml amphotericin B (Sigma,
A5955), 2 mM L-glutamine (Sigma, G-7513) and main-
tained at 5% CO2, and 38.5°C for the experiments de-
scribed below. Medium was replaced after 72 hours for
the first time to remove non-adherent cells and then it
was replaced twice weekly or according to the experimen-
tal design. Adherent cells were detached with 0.05%
trypsin/0.02% EDTA (Euroclone, ECB3052D) just prior to
reaching plate confluence (80%) and then reseeded for cul-
ture maintaining. The cells were expanded for 10 passages.
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To obtain the cell proliferation growth curve, cells at
passage (P) 0 and P3 were seeded into six-well tissue
culture dishes (Costar® Corning, NY, USA. 3516) at a
density of 1 × 103 cells/cm2. Every 2 days, through 14
days of culture, one well of the six-well dishes was tryp-
sinized, and a cell count was performed. The number of
viable cells was obtained by the Trypan blue dye exclu-
sion method using a Burker chamber.
Doubling time (DT) analysis of AECs was also assessed.
Culture passages from P1 to P10 were performed every
four days and the number of viable cells for each passage
was determined by the Trypan blue dye exclusion method
using a Burker chamber. The population DT was obtained
for each passage using the formula DT = CT/CD, where
CT (culture time) is the time between passage “n” and
passage “n + 1” and CD (cell doubling) = ln(Nf/Ni)/ln2,
where Ni represents the seeded cells number and Nf the
harvested cells number.Colony-forming unit assay
Colony-forming unit (CFU) assays were performed at P0
on freshly isolated cells at different densities (100, 250, 500
and 1,000 cells/cm2). Cells were plated in six-well plates
and cultured in 5% CO2 and 90% humidity at 38.5°C for
two weeks in HG-DMEM-supplemented medium. Then,
colonies were fixed with 4% formalin and stained with 1%
methylene blue (Serva, Heidelberg, Germany) in 10 mM
borate buffer, pH 8.8 (Fluka BioChemika, Buchs, Swizer-
land) at room temperature, and washed twice. Colonies
formed by 16 to 20 nucleated cells were counted under a
BX71 microscope (Olympus Italia, Srl, Milano, Italy).RNA extraction and reverse transcription-polymerase
chain reaction (RT-PCR)
Total RNA was extracted from feline amnion-derived cells
at each passage, using TRIReagent (Sigma). Samples were
then treated with DNAse (Sigma, D4263) in order to avoid
DNA contamination. Both steps were performed accord-
ing to the manufacturers’ specifications.
RNA concentration and purity were measured by Nano-
drop Spectrophotometer (Nanodrop® ND1000 Thermo
Scientific, Wilmington, USA). cDNA was synthesized
from total RNA (500 ng) using Taqman Reverse Tran-
scription reagents kit (Applied Biosystems, Life Tecnolo-
gies, Monza, Italy. 4304134).
Qualitative polymerase chain reaction (PCR) was per-
formed in a 25 ml final volume with JumpStart Taq Ready-
Mix (Sigma-Aldrich, P2893) under the following conditions:
initial denaturation at 94°C for 2 minutes, 32 cycles at 94°C
for 30 seconds (denaturation), 55 to 60°C for 30 seconds
(annealing), 72°C for 2 minutes (elongation) and final elong-
ation at 72°C for 5 minutes.The expression of the following set of genes was evaluated
for molecular characterization before in vitro differentiation
of cells: POU class 5 homeobox 1 (POU5F1 alias Oct4),
Nanog homeobox, as pluripotent-ESCs markers; phagocitic
glycoprotein I (CD44), ALCAM (CD166), integrin beta-1
(CD29), 5′ nucleotidase ecto (NT5E alias CD73), thymus
cell surface antigen theta-1 (Thy1 alias CD90), as mesenchy-
mal markers; Gp 105 to 120 (CD34), as hematopoietic
marker; Major Histocompatibility Complex I and II (MHC-
I, MHC-II), as immunogenic markers.
Feline specific primers were initially designed with the
open source PerlPrimer software (v1.1.20, Parkville,
Australia) based on NCBI Felis catus sequences or on mam-
mal multi-aligned sequences, and subsequently manually
improved. Primers were used at 200 nM final concentration.
To test in vitro cell differentiation, the following set of
markers was used: bone gamma-carboxyglutamate osteo-
calcin (OCN) and osteopontin (OPN) for osteogenic
differentiation; adiponectin (ADIPQ) and peroxisome
proliferator-activated receptor γ (PPAR-γ) for adipogenic
differentiation; aggrecan (ACAN) and collagen type 2
chain α1 (COL2A1) for chondrogenic differentiation; nes-
tin (NES) for neurogenic differentiation. Feline mature
tissues (bone, fat, cartilage and spinal cord) were used as
positive controls for the expression of osteogenic, adipo-
genic, chondrogenic and neurogenic markers.
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
was used as reference a gene.
The sequences of each gene are shown in Table 1.
In vitro multipotent differentiation
In order to test their multipotent differentiation poten-
tial, cells at P3 were seeded at a density of 1 x 103/cm2
in six-well tissue culture dishes.
Osteogenic differentiation
For osteogenic differentiation, cells were cultured in HG-
DMEM, supplemented with 10% FBS, 100 U/ml penicillin,
100 μg/ml streptomycin, 0.25 μg/ml amphotericin B, 2
mM/l L-glutamine, 10 mM β-glycerophosphate (Sigma,
50020), 0.1 μM dexamethasone (Sigma, D2915) and 250
μM ascorbic acid (Sigma, A8960). The osteogenic differen-
tiation was assessed by incubating cells for up to three
weeks at 38.5°C with 5% CO2. Non-induced control cells
were cultured for the same time with standard medium
(HG-DMEM supplemented with 10% FBS, 100 U/ml peni-
cillin, 100 μg/ml streptomycin, 0.25 μg/ml amphotericin
B, 2 mM/l L-glutamine). The medium was changed twice
weekly. Presence of calcium deposits in differentiated cells
was verified by von Kossa staining.
Adipogenic differentiation
For adipogenic differentiation, cells were cultured in
HG-DMEM, supplemented with 10% FBS, 100 U/ml
Table 1 Oligonucleotide sequences used for RT-PCR analysis
Gene Primers Product size
Housekeeping gene GAPDH Forward, 5′ – ACGATGACATCAAGAAGGTG – 3′ 180 bp
Reverse, 5′ – CATACCAGGAAATGAGCTTG – 3′
Pluripotent markers Oct4 Forward, 5′ – GGAGTCCCAGGACATCAAAG – 3′ 285 bp
Reverse, 5′ – GCCTGCACAAGTGTCTCTGC – 3′
Nanog Forward, 5′ – ACGGATCCAGCTCAGCCCCA – 3′ 192 bp
Reverse, 5′ – GGGGCTGCCCTGAGCAAGTA – 3′
Mesenchymal markers CD44 Forward, 5′ – TGGGTTGTTTGGCATCCAGTGC – 3′ 100 bp
Reverse, 5′ – CGTTTTCTTCAGTTGGTTCCCAGCC – 3′
CD166 Forward, 5′ – ACTGGCAGTGGAAGCGTCAT – 3′ 275 bp
Reverse, 5′ – CAGCAAGGAGGAGACCA – 3′
CD29 Forward, 5′ – GGAAACTTGGTGGCATTGTT – 3′ 180 bp
Reverse, 5′ – GTTCCTTGTAAACGGGCTGA – 3′
CD73 Forward, 5′ – AGCAAAGGGGCCACTAGCATCT – 3′ 233 bp
Reverse, 5′ – ACCCGAATGTCCCAGTGCAA – 3′
CD90 Forward, 5′ – GAGCACACGTACCGCTCCCG – 3′ 233 bp
Reverse, 5′ – AGCAGCAGCAGCAGCATCCA – 3′
Hematopoietic marker CD34 Forward, 5′ – CTTTAACTGTCACGGCGTTT – 3′ 198 bp
Reverse, 5′ – TGACTCGGGAACATTTGATT – 3′
Immunological markers MHC-I Forward, 5′ – CATCACCCTGAGATGGGAGC – 3′ 176 bp
Reverse, 5′ – TGGGTACTGTCGTCGCGTG – 3′
MHC-II Forward, 5′ – TCCGGAATCAGAAAGGACAC – 3′ 172 bp
Reverse, 5′ – GGCAAACCAAATCCTGAGAA – 3′
Osteogenic markers OCN Forward, 5′ – CTGCCTCTGCCTGGCTGGTC – 3′ 120 bp
Reverse,5′ – TAGCGCCGGAGCCTCCTCAC – 3′
OPN Forward, 5′ – ACTGGTCACTGATTTTCCCACGGA – 3′ 100 bp
Reverse, 5′– AACCACACTATCACCTCGGCCA – 3′
Adipogenic markers ADPQ Forward, 5′ – TGAGAAAGGAGATCCAGGTC – 3′ 308 bp
Reverse, 5′ – TCAAGTAGACTGTGATGTGG – 3′
PPAR-γ Forward, 5′ – CATGGTTGACACAGAGATGC – 3′ 239 bp
Reverse, 5′ – GCTCCACTTTGATTGCACTTTG –3′
Chondrogenic markers ACAN Forward, 5′ – AAGTGGAGCCGCGTTTCCAAGG – 3′ 163 bp
Reverse, 5′ – AGTCATTGGAGCGCAGGTTCTGG – 3′
COL2A1 Forward, 5′ – AGTTGGGAGTAATGCAAG – 3′ 294 bp
Reverse, 5′ – GATAACCTCTGTGACCTTTG – 3′
Neurogenic marker NES Forward, 5′ – AAACAGGGCCTACAGAG – 3′ 293 bp
Reverse, 5′ – ACAGGTGTCTCAAGGGTAG – 3′
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tericin B, 2 mM/l L-glutamine, 10 μg/ml insulin (Sigma
I-6634), 150 μM indomethacin (Sigma I-7378), 1 μM
dexamethasone and 500 μM IBMX (3-isobutyl-methyl-
xanthine, Sigma I-7018) and the adipogenic differenti-
ation was assessed by incubating cells for up to three
weeks at 38.5°C with 5% CO2. Non-induced control cells
were cultured for the same time with standard medium.
The medium was changed twice weekly. Differentiationwas evaluated by Oil Red-O staining (Sigma, O0625),
which dye intracytoplasmatic lipid droplets.
Chondrogenic differentiation
For chondrogenic differentiation, cells were cultured in
DMEM low-glucose, containing 100 U/ml penicillin,
100 μg/ml streptomycin, 0.25 μg/ml amphotericin B,
2 mM/l L-glutamine, 100 nM dexamethasone, 50 μg/ml
L-ascorbic acid 2-phosphate, 1 mM sodium pyruvate
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ITS (insulin 5 μg/ml, transferrin 5 μg/ml, selenous acid 5
ng/ml; Sigma, I3146) and 5 ng/ml transforming growth
factor-β3 (Peprovet, DBA Milano, Italy. 100-36E). The
chondrogenic differentiation was assessed by incubating
cells for up to three weeks at 38.5°C with 5% CO2. Non-
induced control cells were cultured for the same time with
standard medium. The medium was changed twice
weekly.
Differentiation was evaluated by Alcian blue (Sigma,
89640) staining.
Neurogenic differentiation
The neurogenic differentiation was performed by incubating
cells in a pre-induction medium consisting of HG-DMEM,
20% FBS and 1 mM β-mercaptoethanol (Sigma, M7522) for
24 h; then the neuronal induction was performed with a
medium composed of HG-DMEM supplemented with 2%
FBS, 2% dimethylsulfoxide (Sigma, D-5879) and 200 μM
butylated hydroxyanisole (Sigma, B-1253) for three days.
Non-induced control cells were cultured for the same time
with standard medium. Differentiation was evaluated by
Nissl staining to stain Nissl bodies.
The occurred differentiation was confirmed perform-
ing RT-PCR on undifferentiated (controls) and induced
AECs (control cells) as described above.
Detection of SSEA-3 and SSEA-4 markers by immunocyto-
chemistry and flow cytometry
To test the expression of SSEA-3 and SSEA-4, as embry-
onic markers, primary rat and mouse antibodies respect-
ively were purchased from Abcam (Cambridge, MA, USA),
while Alexafluor-488 conjugated secondary antibodies were
from Invitrogen (Carlsbad, CA, USA). All products were
used following the manufacturer’s instructions.
Immunocytochemical characterization
For immunostaining, cells at P3 were fixed in 3.7% para-
formaldehyde (PFA) for 15 minutes and washed three
times in PBS. After that, cells were blocked using 2% bo-
vine serum albumin (BSA) in PBS for 4 h at 4°C. Cells
were incubated with primary antibodies overnight at 4°C.
After washing three times, cells were incubated with rabbit
anti-mouse and anti-rat Alexa Fluor 488-conjugated sec-
ondary antibody (1:250 dilution) for 1 h. Finally, for nu-
clear staining, cells were incubated for 15 minutes with
Hoechst 33342 (1 mg/ml; Sigma) diluted 1:100 in PBS.
The specificity of the immunostaining was tested by in-
cluding negative controls, performed by use of non-
immune mouse and rat serum (Santa Cruz Biotechnology
Inc., Heidelberg, Germany) in place of specific antisera,
and omission of the primary antibody.
Images were captured on a BX 51 microscope (Olympus,
Japan).Flow cytometry (FCM) analysis
At P3, AECs (2 x 106 cells/ml) were labeled with primary
antibodies for SSEA-3 and SSEA-4 in 3% BSA (BDH,
VWR International Ltd., Poole, UK) in PBS for 45 mi-
nutes at room temperature in the dark. After that, cells
were washed in cold PBS and incubated with secondary
AlexaFluor-488 conjugated antibodies (1:250) for 30 mi-
nutes at room temperature in the dark. Labeled cells
were washed twice in ice cold PBS and analyzed using
an Epics Coulter flow cytometer (Beckman Coulter-IL,
Fullerton, CA, USA). A minimum of 10,000 cells were
acquired for the evaluation of each antibody and analyzed
in the FL1 channel. All analyses were based on control cells
incubated with isotype-specific IgG or IgM to establish
the background signal. Files analysis was performed using
Weasel software v.2.5 available online (Parkville, Australia)
[46].
Statistical analysis
Statistical analysis was performed using GraphPad Instat
3.00 for Windows (GraphPad Software, La Jolla, CA, USA).
Three replicates for each experiment (growth curves, doub-
ling times and CFU) were performed and the results are
reported as mean standard deviation (SD). One-way ana-
lysis of variance (ANOVA) for multiple comparisons by
Student-Newman-Keuls multiple comparison tests was
used. CFU comparison among different cell plating dens-
ities inside each group was analyzed. P <0.05 was consid-
ered as significant.
Results
Amnion collection and isolation of amniotic epithelial cells
Cells adhered to culture dishes and in the first culture dis-
played initial morphological heterogeneity with epithelial,
fibroblastic-like and circular cells. Subsequently, a typical
polygonal epithelial morphology was recognized. More-
over, clusters of rapidly expanding cells were observed.
Representative images are shown in Figure 1.
Proliferation assay: growth curve and doubling time
analysis
Studying the growth curve of feline AECs it was possible
to observe at P0 a slow plating efficiency with a lag
phase of 48 hours compared to cells at P3 that showed
an immediate and intensive log phase until the ninth
day. In both curves there was a final plateau phase from
the 9th to the 14th day (Figure 2).
At P1 and P2, the population DT was higher com-
pared to the other passages, with mean values of 5.2 ±
0.25 and 3.6 ± 0.09 days, respectively. From P3 to P10,
the mean DT value was 1.25 ± 0.14 days. Differences were
statistically significant comparing P1 with P2 (P <0.05)
and highly significant comparing P1 with the subsequent
passages (P <0.01) (Figure 2).
Figure 1 Cell morphology. (A) Monolayer of cells in first culture and (B) at passage 3 (P3); (C) Amniotic epithelial cells (AECs) with cluster.
Magnification 20×; scale bar = 20 μm.
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The number of cell colonies formed was counted at P0 after
seeding cells at different density/cm2. AECs demonstrated
a statistically significant increase in CFU frequency with in-
creasing cell-seeding densities (Table 2).RNA extraction and RT-PCR analysis
As shown by RT-PCR, AECs expressed the pluripotency-
associated markers Oct-4 and Nanog: mRNAs for Oct-4
were detected over the passages studies, whereas those for
Nanog were only expressed at the first passages (P2 and
P3) and surprisingly at P7. Cells also showed expression
for some of the mesenchymal stem cell- (MSC-)associated
markers (being positive for CD44 at each passage and for
CD166 from P3 to P7) and lacked of the hematopoietic
marker CD34. Expression for other MSC-specific markers
(CD29, CD73 and CD90) has not been registered at any
stage. MHC-I expression was demonstrated in each cell
population, whereas MHC-II was not. Figure 3 shows the
expression of the specific genes evaluated.In vitro multipotent differentiation
Osteogenesis
After three weeks of culture in osteogenic induction
medium, feline AECs distinctly changed their morph-
ology and were surrounded by calcium deposits posi-
tive to von Kossa staining. In controls, cells did notchange in morphology and did not stain positively to
von Kossa.
The osteogenic differentiation was confirmed by the ex-
pression of OPN and OCN mRNAs. A weak expression of
OCN was also registered in the controls (Figure 4A).
Adipogenesis
In cells induced to differentiate into adipocytes, the pres-
ence of intracytoplasmatic lipids droplets was evident after
three weeks, whereas control cells showed no lipid deposits.
Molecular analysis confirmed the induction revealing the
expression of PPAR-γ, whereas mRNAs for adiponectin
were not detected (Figure 4B).
Chondrogenesis
Cells grown in chondrogenesis-inducing medium stained
positively for Alcian Blue, demonstrating a marked depos-
ition of metachromatic extracellular matrix composed by
glycosaminoglycans. Controls did not change in morph-
ology and were negative to Alcian blue staining. RT-PCR
showed that differentiated cells express ACAN and
COL2A1, confirming the induction (Figure 4C).
Neurogenesis
When induced into neurogenic lineage, cells showed an
increased presence of Nissl bodies and displayed the
typical neuronal morphology with axon- and dendrite-
like processes, as compared to the polygonal epithelial
Figure 2 Proliferation assay. AECs growth curve at P1 and P3; doubling times at different passages during cell culture. Letters represent
doubling time means statistically different. a, b: P <0.05; c, d: P <0.01.
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tions. RT-PCR confirmed the neurogenic differentiation
(Figure 4D).
Detection of SSEA-3 and SSEA-4 markers by immunocyto-
chemistry and flow cytometry
Only immunopositivity to the stem cell markers SSEA-4
was detected. AECs expressed this antigen on the cell
surface (Figure 5A).
FCM analysis revealed that AECs were negative for
SSEA-3 while 85% of cells showed SSEA-4 reactivity
(Figure 5B).Table 2 CFU assay
Density cells/cm2 Total cells CFU 1 CFU each
AECs 100 950 1.82 ± 0.72a 521.98
250 2,375 15.93 ± 1.39b 149.09
500 4,750 20.54 ± 2.72c 231.25
1,000 9,500 37.43 ± 2.67d 253.81
Different small letters superscripts (a, b, c, d) indicate statistically different
comparisons (P <0.05) between cell densities in each group (amniotic
epithelial cells (AECs)).Discussion
The identification of the optimal source of stem cells
represents a critical issue for cell therapy, in order to ob-
tain a relevant amount of cells and to minimize risks for
the donors and the recipients. For these purposes, amni-
otic membrane is a valid alternative, in particular for the
isolation of epithelial cells [23,27,36,37]. Despite the im-
portance of the domestic cat in studying human genetic
and viral diseases, to our knowledge no studies have
been performed on feline amniotic epithelial cells.
In the present study, for the first time, we have iso-
lated and expanded AECs from feline amnion that is an
extra-fetal tissue and thus retains higher proliferation
and differentiation potential respect to cells deriving
from adult compartments. Cells, easily isolated through
enzymatic digestion, showed typical polygonal epithelial
morphology and were able to be sub-cultured in vitro.
The proliferation study (growth curve) showed that
AECs reached high plating efficiency at P3, as demon-
strated by the short lag phase in respect to P0. This re-
sult was probably due to the fact that the first culture is
composed of a heterogeneous cell population that
Figure 3 RT-PCR analysis. Pluripotent (Oct4 and Nanog), mesenchymal (CD44, CD166, CD29, CD73, CD90) and hematopoietic (CD34) specific
gene expression on AECs from P1 to P9. Major Histocompatibility Complex (MHC) I and II gene expression is also reported. GAPDH was used as
reference gene. AECs, amniotic epithelial cells.
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but in contrast with data reported in literature [36,38],
the DT analysis revealed a high value for the first pas-
sages (P1: 5.19 ± 0.25 days; P2: 3.62 ± 0.09 days). To con-
firm our hypothesis, on the other hand, the initial
heterogeneity of cell population was also recognized
morphologically during the primary culture (at P0),
when fibroblastic-like and circular cells were present. By
the first passage, a selection of typical polygonal epithe-
lial cells occurred and from P3 to P9 the proliferation
rate increased with a mean DT value of 1.24 ± 0.17 days,
suggesting that at P3 AECs reached the sufficient levels
of homogeneity. This indicates the higher proliferating
ability of the isolated AECs, in accordance with Miki et
al. [38] and Parolini et al. [36] in humans, and with
Lange-Consiglio et al. [27] in equine species, who re-
ported robust proliferation at least up to P6.
When AECs were seeded at different densities, they
were able to form clones with frequency that increased
with the cell-seeding density, suggesting that paracrine
signaling between cells at P0 occur [47]. Moreover, when
AECs are kept in high-density cultures, small cell clus-
ters or spheroid structures developed, showing that these
cells did not have contact-inhibited cell growth and con-
tinue to proliferate after reaching 100% surface conflu-
ence, forming aggregates overlying the monolayer of
confluent cells. Miki et al. [32,34,38] report that the am-
niotic cells in monolayer may support the growth and
maintain undifferentiated the amniotic cells of spheroidstructures, possibly playing the role of an autologous
feeder layer and providing secreted factors.
Molecular characterization by RT-PCR showed the ex-
pression of some of the pluripotency-associated tran-
scription factors, as Oct4 at each of the passages studied,
in agreement with data reported in previous studies
[26,27,32-34,36,37,39,42]. In particular, Oct4 is known to
play a critical role in maintaining pluripotency and self-
renewal of the epiblast and it is down-regulated during
gastrulation, suggesting that amniotic epithelium could
maintain the potency of undifferentiated epiblast [32].
Nanog was only expressed at the first passages (P2 and
P3) and surprisingly at P7. These data could be due to
the relative heterogeneity of cells and/or to the changes in
membrane expression markers that may occur from one
culture passage to another, as observed by Corradetti
et al. [48] in the horse. AECs did express CD44 and
CD166 from P3 to P9 but lacked the expression of
other mesenchymal markers, as CD29, CD73 and CD90,
confirming the heterogeneity observed by the proliferation
studies. Bilic et al. [48,49] reported that human AECs
had an antigen expression profile characteristic of cul-
ture-expanded MSCs and could co-express epithelial
and mesenchymal cell markers [50]. In fact, it has been
reported that the amnion-derived cells have not completely
differentiated into epithelial or mesenchymal phenotype,
or another explanation is that the epithelial-mesenchymal
transition may occur in the amniotic membrane [49,50].
Expression of the hematopoietic marker CD34 was not
Figure 4 Staining of differentiated and control undifferentiated feline AECs and respective molecular expression. A) von Kossa staining
after osteogenic induction and RT-PCR analysis of osteopontin (OPN) and osteocalcin (OCN). B) Oil Red-O positive cytoplasmic neutral lipids after
adipogenic induction and RT-PCR analysis of PPAR-γ and adiponectin (ADPQ). C) Alcian blue staining after chondrogenic induction and RT-PCR of
aggrecan (ACAN) and collagenase (COL2A1). D) Nissl staining after neurogenic induction and RT-PCR of nestin. Magnification 20×; scale bar = 20
μm. GAPDH was employed as a reference gene. Bone, adipose tissue, cartilage and spinal cord were used as positive controls. AECs, amniotic
epithelial cells.
Rutigliano et al. Stem Cell Research & Therapy 2013, 4:133 Page 9 of 13
http://stemcellres.com/content/4/5/133found at any passage. This result was expected, and
it confirmed that isolated cells do not belong to a
hematopoietic lineage. Furthermore, isolated cells seem
to be immune-privileged, as confirmed by the expres-
sion of MHC-I and the absence of MHC-II expression
over the passages studied. The lack of this marker
hints at potential application of these cells to allo- and
xeno-transplantation, in agreement with previous studies
[27,32,33,36,37,39,42,51].
It is important to underline that RT-PCR alone is not
useful for characterizing AECs and that quantitative ana-
lysis are needed to make meaningful statements about
their gene expression. The investigation with flow cy-
tometry provides useful quantitative data on the percent-
age of reactivity, but, as reported by Iacono et al. [30],
there are no commercially available feline species-
specific antibodies for characterization of these MSCs.
In addition to molecular characterization by RT-PCR,
we tried to detect the immunopositivity of amniotic fe-
line epithelial cells to SSEA-3 and SSEA-4 that are cell
surface globo-series glycosphingolipid epitopes that arecommonly used as markers for human embryonic stem
cells [52,53]. Lately, SSEA-3 and -4 have also been ob-
served in MSCs from different origin [54-57]. Our data
showed that 85% of cultured cells display SSEA-4 on
their surface but not SSEA-3. One interpretation of
these findings could be that amnion-derived cells have a
subset of primitive stem cells. In this regard, it is note-
worthy that the epithelial layer of horse amnion has the
same epiblastic origin [58] as the human layer, and it is
therefore reasonable to speculate that some AECs may
have escaped the specification that accompanies gastru-
lation, and that these cells may retain some or all of the
characteristics of epiblastic cells, such as pluripotency
[32]. In contrast to SSEA-4, SSEA-3 epitope was not de-
tected in feline AECs. Probably this result is not a sur-
prise because it is known that SSEA-3 is extinguished
more rapidly from the cell surface than SSEA-4 during
embryonic stem-cell differentiation [59,60].
Further investigation will be required in order to deter-
mine whether the amniotic cells, positive to some stem
cell marker, are remnants of the pluripotent cells from the
Figure 5 Immunostaining and cytometry analyses of SSEA-3 and SSEA-4 antigens. A) Photomicrographs of immunostaining of feline
amniotic epithelial cells (AECs). Cells labeled with antibodies against antigen SSEA-4. Magnification 20×, scale bar = 20 mm. B) Flow cytometry
analysis of SSEA-3 and SSEA-4 antigen expression with Alexafluor-488 labeled antibodies. Histograms represent relative number of cells vs. fluorescence
intensity (FL1). Black histograms indicate background fluorescence intensity of cells labeled with isotype control antibodies only; gray histograms show
positivity to the studied antibodies.
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for a separate and specific function which has yet to be de-
termined. As reported by Miki and Strom [32], if placental
stem cells are maintained throughout the pregnancy, the
mechanism and the functional implications of this will be
the basis of future exploration.
In an effort to determine the plasticity of AECs,
in vitro differentiation assays have been performed and
despite the lack of expression of some stem cell marker,
it was possible to define feline AECs as presumptive
stem cells. Nes expression, the Nissl staining and the
changes in morphology observed suggested neuronaldifferentiation of the cells when kept under neurogenic
culture condition, confirming their ability to differentiate
into the ectodermal lineage. Furthermore, under in vitro
induction conditions, we were able to differentiate feline
AECs toward two mesodermal lineages, such as osteo-
cytes and chondrocytes. These data were confirmed by
specific gene expression analysis and specific stainings,
and are in accordance with those previously reported for
human, equine and ovine AECs [26,27,33]. When stimu-
lated to differentiate toward the adipogenic lineage, how-
ever, AECs expressed only mRNA for PPAR-γ that is
crucial for the pre-adipocyte commitment [61]. The lack
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tein exclusively synthesized in white adipose tissue [62],
might be led to the culture conditions employed in this
study or to some specific characteristics of the feline
AECs that need more time for adipogenic differentiation
compared to other cell lines. Other extra-fetal cell lines,
as umbilical cord blood (UCB)-derived stem cells,
present much less obvious adipogenic differentiation
than bone marrow- or adipose-derived MSCs [63,64].
Bieback et al. [65] did not obtain adipocytes after culture
of human UCB cells in standard induction medium,
containing dexamethasone, IBMX, insulin, indomethacin
and FBS. However, continuous culture in induction
medium for five weeks did result in some adipogenic dif-
ferentiation. Similarly, only sporadic fat cells containing
limited amounts of lipid droplets were evident in equine
UCB cell cultures after 21 days in adipocyte induction
media [66]. Lee et al. [67] achieved adipogenic differenti-
ation but only after the addition of rabbit serum to the
induction medium. Kern et al. [12] reported a failure of
human UCB cells to induce differentiation into adipo-
cytes, even following five weeks of culture.
In the effort to check pancreatic differentiation (endo-
dermic lineages), by different protocols, differentiation
was not obtained in this cell line, in our opinion due
mainly to technical problems (see Additional file 1).
Since these cells differentiated into two germ layers
(mesodermic and ectodermic), feline AECs could be de-
fined as multipotent, unlike human amniotic epithelial
stem cells that showed pluripotency by the ability to dif-
ferentiate into all three germ layers [34].
Conclusions
In conclusion, although BM-derived cells have received
the most attention and are thus the best characterized,
the procedure to isolate these cells requires significant
time in culture and the recovery efficiency is low. This
lag time prevents earlier use of these cells, which may
prove to be suboptimal. AECs have no lag time in cul-
ture as they are isolated and cultured at birth or during
ovario-hysterectomy. Moreover, these cells are capable
of differentiation into two germ lines and have low im-
munogenicity, making them an ideal candidate for allo-
geneic implantation.
From the results obtained, it is possible to say that feline
amniotic membrane, that could be collected at the deliv-
ery, during caesarean section or after ovariohysterectomy
of pregnant queens, may be considered as a remarkable
source of multipotent stem cells in cats, available for fu-
ture efforts in cell therapy. However, further studies, in-
cluding pre-clinical, and a deeper evaluation of stemness
properties (as pancreatic differentiation, telomerase activ-
ity, clonal expansion, unrestricted growth, teratoma for-
mation in mice) are needed for the in vivo applications inorder to better understand their applicability for tissue re-
generation in vivo and immune host reaction.
Additional file
Additional file 1: Pancreatic differentiation. Supplementary
information on protocols, results and discussion regarding the
experiments aimed to evaluate the endodermic lineage differentiation of
feline progenitor like amniotic epithelial cells.
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